HIGHLIGHTS
- who: Mayar Allam from the Published in partnership with The Hormel Institute, University of Minnesota have published the Article: Spatially variant immune infiltration scoring in human cancer tissues, in the Journal: (JOURNAL)
- what: The main reason behind the poor success rates of immunotherapies is the lack of understanding of the molecular and cellular drivers of the tumor-driven immune changes between patients across different cancer stages and grades2. There was an unexpected expression from the TCF1 in double-negative cells (CD8u0251- CD4-), which is not the main focus of this paper and is currently under . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.